DANISH BIO – DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately four "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

News

How much is a Senior Research Scientist paid? Find the answer in The Danish Biotech Salary Survey 2023. 13 March 2023

Finding the right balance between salary costs and the ability to attract and retain key talent is crucial... Read more

Y-mAbs and the European Medicines Agency Reach Agreement on the Pediatric Investigation Plan for Naxitamab 02 February 2023

NEW YORK, Feb. 02, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more

Unilabs og Siemens Healthineers lancerer strategisk partnerskab, for at den nyeste diagnostiske testinfrastruktur kan medvirke til at forbedre patienters pleje 02 February 2023

Genève og Erlangen – 2. februar 2023: Unilabs, en førende udbyder af diagnostiske services, og Siemens... Read more

Dansk Erhverv har lavet en ny life science-politik: Vi kan nå endnu længere, hvis vi justerer rammevilkårerne 02 February 2023

Efter et solidt politisk fokus på life science-området, mener Dansk Erhverv ikke, at foden skal slippes... Read more

IO Biotech får lovende fase 2-data 17 January 2023

Biotekselskabet IO Biotech har fået opløftende foreløbige resultater fra et fase 2-forsøg mod lungekræft. Mens... Read more

Nyt netværk for kvinder i life science får støtte fra Novo Nordisk Fonden 10 January 2023

Et nyt fagligt netværk for kvindelige topledere og specialister med prominente life science-kapaciteter... Read more

MinervaX appoints Lidia Oostvogels as Chief Medical Officer and provides clinical and regulatory update on its novel GBS vaccine 05 January 2023

Newly appointed CMO with more than 25 years’ experience in vaccine development Fast Track status granted... Read more

Y-mAbs Announces Restructuring Plan and Provides Financial Outlook Following Complete Response Letter from FDA 04 January 2023

Estimated 28% reduction in annual operating expenses for 2023 compared to previously announced guidance... Read more

Y-mAbs Announces Partnership Regarding Early Access Program for DANYELZA (naxitamab-gqgk) in Europe 21 December 2022

NEW YORK, Dec. 21, 2022 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more

Copyright 2022 DANISH BIO – DANSK BIOTEK. All rights reserved.

created by: Mastafu Design